Literature DB >> 23254782

Overexpression of LASP1 is associated with proliferation, migration and invasion in esophageal squamous cell carcinoma.

Bin He1, Bangliang Yin, Baoxiang Wang, Chen Chen, Zhenkun Xia, Jingqun Tang, Yunchang Yuan, Xiang Feng, Ni Yin.   

Abstract

LIM and SH3 protein 1 (LASP1) is an actin-binding protein which is overexpressed in many types of cancers and plays important roles in cancer progression. however, the role of LASP1 in esophageal squamous cell carcinoma (ESCC) is still unknown. We sought to analyze the expression level of LASP1 in ESCC, and the role of LASP1 in the development of ESCC was further investigated. We evaluated the expression levels of LASP1 in 89 ESCC tissues and two ESCC cell lines using quantitative real-time polymerase chain reaction, western blotting and immunohistochemistry. The effects of LASP1 depletion on tumor cell behavior were investigated using gene transfection and small interfering RNA (siRNA) in ESCC cell lines in vitro. The expression levels of LASP1 at the mRNA and protein levels were significantly higher in ESCC tissues and ESCC cell lines compared to adjacent tissues. Immunohistochemistry showed that LASP1 was localized in the cytoplasm and nuclei of tumor epithelia. Silencing of LASP1 in ECA109 and KYSE510 cell lines significantly inhibited cell proliferation, migration and invasion when compared with the negative control cells in vitro. LASP1 may play an important role in the pathogenesis of ESCC and shows promise as a treatment target in ESCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23254782     DOI: 10.3892/or.2012.2199

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Expression of migfilin is increased in esophageal cancer and represses the Akt-β-catenin activation.

Authors:  Huan He; Fang Ding; Sheng Li; Hongyan Chen; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

2.  miR-143 inhibits migration and invasion through regulating LASP1 in human esophageal cancer.

Authors:  Huifeng Liu; Mengli Zheng; Yachao Zhao; Shuxin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

3.  Long non-coding RNA LINC00672 contributes to p53 protein-mediated gene suppression and promotes endometrial cancer chemosensitivity.

Authors:  Wei Li; Hua Li; Liyuan Zhang; Min Hu; Fang Li; Jieqiong Deng; Mingxing An; Siqi Wu; Rui Ma; Jiachun Lu; Yifeng Zhou
Journal:  J Biol Chem       Date:  2017-02-23       Impact factor: 5.157

4.  LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.

Authors:  Cas Vanderheijden; Thomas Vaessen; Youssef Yakkioui; Robert Riedl; Yasin Temel; Koos Hovinga; Govert Hoogland
Journal:  J Neurooncol       Date:  2022-05-04       Impact factor: 4.506

Review 5.  An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.

Authors:  Martin F Orth; Alex Cazes; Elke Butt; Thomas G P Grunewald
Journal:  Oncotarget       Date:  2015-01-01

6.  Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1.

Authors:  Pin-Dong Li; Jian-Li Hu; Charlie Ma; Hong Ma; Jing Yao; Li-Li Chen; Jing Chen; Tian-Tian Cheng; Kun-Yu Yang; Gang Wu; Wen-Jie Zhang; Ru-Bo Cao
Journal:  Oncotarget       Date:  2017-05-23

7.  Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).

Authors:  Marcel Endres; Susanne Kneitz; Martin F Orth; Ruwan K Perera; Alma Zernecke; Elke Butt
Journal:  Oncotarget       Date:  2016-09-27

8.  Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway.

Authors:  Xiupeng Zhang; Yang Liu; Chuifeng Fan; Liang Wang; Ailin Li; Haijing Zhou; Lin Cai; Yuan Miao; Qingchang Li; Xueshan Qiu; Enhua Wang
Journal:  Oncotarget       Date:  2017-08-24

9.  Hsa_circ_0004370 promotes esophageal cancer progression through miR-1294/LASP1 pathway.

Authors:  Zhenyang Zhang; Wenwei Lin; Lei Gao; Keqing Chen; Chuangcai Yang; Linwei Zhuang; Shuai Peng; Mingqiang Kang; Jiangbo Lin
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

10.  Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.

Authors:  Rika Nishikawa; Yusuke Goto; Shinichi Sakamoto; Takeshi Chiyomaru; Hideki Enokida; Satoko Kojima; Takashi Kinoshita; Noriko Yamamoto; Masayuki Nakagawa; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Cancer Sci       Date:  2014-06-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.